TG Therapeutics Total Assets 2006-2019 | TGTX

TG Therapeutics total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
TG Therapeutics Annual Total Assets
(Millions of US $)
2018 $84
2017 $97
2016 $55
2015 $113
2014 $87
2013 $48
2012 $22
2011 $15
2010 $19
2009 $0
2008 $1
2007 $1
2006 $3
2005 $11
TG Therapeutics Quarterly Total Assets
(Millions of US $)
Q2 2019 $107
Q1 2019 $118
Q4 2018 $84
Q3 2018 $114
Q2 2018 $141
Q1 2018 $121
Q4 2017 $97
Q3 2017 $102
Q2 2017 $101
Q1 2017 $123
Q4 2016 $55
Q3 2016 $76
Q2 2016 $95
Q1 2016 $100
Q4 2015 $113
Q3 2015 $127
Q2 2015 $124
Q1 2015 $117
Q4 2014 $87
Q3 2014 $78
Q2 2014 $56
Q1 2014 $58
Q4 2013 $48
Q3 2013 $54
Q2 2013 $18
Q1 2013 $21
Q4 2012 $22
Q3 2012 $25
Q2 2012 $27
Q1 2012 $27
Q4 2011 $15
Q3 2011 $18
Q2 2011 $18
Q1 2011 $19
Q4 2010 $19
Q3 2010 $19
Q2 2010 $20
Q1 2010 $20
Q4 2009 $0
Q3 2009 $1
Q2 2009 $1
Q1 2009 $2
Q4 2008 $1
Q3 2008 $0
Q2 2008 $1
Q1 2008 $1
Q4 2007 $1
Q3 2007 $2
Q2 2007 $5
Q1 2007 $9
Q4 2006 $3
Q3 2006 $5
Q2 2006 $8
Q1 2006 $9
Q4 2005 $11
Q3 2005 $13
Q2 2005 $3
Q1 2005 $4
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.624B $0.000B
TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various B-cell proliferative disorders including lymphoma, leukemia, and auto-immune diseases. TG Therapeutics, Inc., formerly known as Manhattan Pharmaceuticals, Inc., is based in New York.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.330B 27.69
Medtronic (MDT) Ireland $146.309B 20.54
Stryker (SYK) United States $80.541B 27.85
Boston Scientific (BSX) United States $58.421B 28.34
Baxter (BAX) United States $44.378B 26.91
EssilorLuxottica Societe Anonyme (ESLOY) France $31.384B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.264B 18.09
Lonza Group Ag (LZAGY) Switzerland $24.906B 0.00
Coloplast (CLPBY) Denmark $24.894B 39.74
Terumo (TRUMY) Japan $22.254B 25.59
Smith & Nephew SNATS (SNN) United Kingdom $20.394B 0.00
ResMed (RMD) United States $18.779B 35.81
Sunny Optical Technology (SNPTF) China $16.365B 0.00
Bio-Rad Laboratories (BIO) United States $9.957B 53.38
Canopy Growth (CGC) Canada $9.657B 0.00
Insulet (PODD) United States $8.625B 511.07
Perrigo (PRGO) Ireland $7.714B 14.21
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.923B 20.64
Haemonetics (HAE) United States $6.394B 48.25
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.561B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.233B 0.00
Neogen (NEOG) United States $4.125B 68.48
NuVasive (NUVA) United States $3.402B 27.12
ICU Medical (ICUI) United States $3.401B 22.06
Hutchison China MediTech (HCM) China $2.728B 0.00
Quidel (QDEL) United States $2.681B 26.62
Agios Pharmaceuticals (AGIO) United States $2.216B 0.00
National Vision Holdings (EYE) United States $2.181B 47.07
Cardiovascular Systems (CSII) United States $1.821B 0.00
Aphria (APHA) $1.659B 0.00
VAREX IMAGING (VREX) United States $1.115B 25.70
AtriCure (ATRC) United States $0.998B 0.00
Lantheus Holdings (LNTH) United States $0.977B 25.69
Omeros (OMER) United States $0.949B 0.00
Phibro Animal Health (PAHC) United States $0.894B 14.54
Eagle Pharmaceuticals (EGRX) United States $0.803B 20.47
NanoString Technologies (NSTG) United States $0.779B 0.00
PetIQ (PETQ) United States $0.763B 18.03
Cerus (CERS) United States $0.755B 0.00
LeMaitre Vascular (LMAT) United States $0.702B 41.63
MacroGenics (MGNX) United States $0.652B 0.00
Surmodics (SRDX) United States $0.640B 121.56
Quanterix (QTRX) United States $0.638B 0.00
OraSure Technologies (OSUR) United States $0.469B 21.71
Meridian Bioscience (VIVO) United States $0.427B 13.32
BioLife Solutions (BLFS) United States $0.392B 128.81
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.391B 0.00
Owens & Minor (OMI) United States $0.378B 11.32
Utah Medical Products (UTMD) United States $0.370B 27.14
United Health Products (UEEC) United States $0.330B 0.00
Zynex (ZYXI) United States $0.290B 30.83
Bovie Medical (APYX) United States $0.243B 0.00
Rockwell Medical (RMTI) United States $0.204B 0.00
Cytosorbents (CTSO) United States $0.179B 0.00
Vapotherm (VAPO) United States $0.165B 0.00
Fonar (FONR) United States $0.150B 10.69
Chimerix (CMRX) United States $0.141B 0.00
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.118B 0.00
InfuSystems Holdings (INFU) United States $0.106B 0.00
United-Guardian (UG) United States $0.087B 20.54
MRI Interventions (MRIC) United States $0.067B 0.00
Surface Oncology (SURF) United States $0.062B 0.00
Nephros (NEPH) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.026B 0.00
GUARDION HEALTH (GHSI) United States $0.014B 0.00
Myomo (MYO) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00